Malignant pleural mesothelioma (MPM) is a rare and aggressive malignant disease affecting
the mesothelium, commonly associated to asbestos exposure. Therapeutic actions are …

Hypothesis The tumor micro-environment and especially the different macrophage
phenotypes appear to be of great influence on the behavior of multiple tumor types. M1 …

MPM remains difficult to treat and has an overall poor prognosis despite current
multimodality treatment. Thoracoscopy with multiple pleural biopsies can provide adequate …

Malignant pleural mesothelioma (MPM) is a rare, but severe form of cancer, with an
incidence that varies significantly within and among different countries around the world. It …

Advances in the treatment of malignant pleural mesothelioma (MPM) have been
disappointing, despite the apparent need for new therapeutic options for this rare and …

Malignant pleural mesothelioma (MPM) is a rare disease of the pleura and is largely related
to asbestos exposure. Despite recent advancements in technologies and a greater …

Background The role of immunotherapy in cancer is now well-established, and therapeutic
options such as checkpoint inhibitors are increasingly being approved in many cancers such …

Malignant pleural mesothelioma (MPM) is a disease with a poor prognosis due to its
aggressive nature. The management of patients with MPM is controversial. Considering that …

Introduction Clinical studies have demonstrated beneficial effects of immunotherapy in
malignant pleural mesothelioma. The pleural cavity seems an attractive compartment to …

The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …